Opinion of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics
AIRBUS-ATB
Evaluation of Informal Opinions of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics in General Medicine
1 other identifier
observational
4,138
1 country
13
Brief Summary
The increase in bacterial resistance and the overuse of antibiotics have led health authorities to propose incentives for the proper use of antibiotics. Among these measures, the introduction of referring physicians for antibiotic therapy and tele-advisory devices for infectious diseases have shown positive effects on antibiotic prescriptions in hospitals. Today, an increase is observed in the consumption of antibiotics linked to ambulatory prescriptions. The objective of the project is to deploy tele-advice devices for general practitioners and to evaluate the effects on ambulatory antibiotic dispensing. AIRBUS-ATB is a prospective, multi-center, population-based, interrupted time-series observational study with a control group with 12 points before and 24 points after the deployment of the intervention in voluntary territories.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Typical duration for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2019
CompletedFirst Submitted
Initial submission to the registry
September 28, 2020
CompletedFirst Posted
Study publicly available on registry
October 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 30, 2023
May 1, 2023
3.2 years
September 28, 2020
May 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from monthly outpatient antibiotic dispensation expressed in Defined Daily Dose (DDD) at 24 months
Monthly outpatient antibiotic dispensation expressed in Defined Daily Dose (DDD) overall and by antibiotic classes in relation to the number of inhabitants per department present in the EGB.
12 months before the deployment of telecommunication devices and 24 months after the deployment
Secondary Outcomes (6)
Number of opinions given by participating infectious diseases specialists
One year period
Number of requesting GPs relative to the number of GPs in the health territories studied
One year period
Compliance with advice by GPs
One year period
Number of advice that has induced an action on the patient's care pathway
One year period
Time spent by the infectiologists to respond to the advice
One year period
- +1 more secondary outcomes
Study Arms (2)
Experimental group
12 departments in mainland France covered by the tele-advice system open to general practitioners
Control group
84 departments in mainland France not covered by the tele-advice system.
Interventions
The intervention consists of setting up in each participating center an infectious disease tele-advice system available to general practitioners via a dedicated mobile telephone line.
Eligibility Criteria
The main study population consists of the dispensations of systemic antibiotics recorded by the health insurance in the base of the general sample of beneficiaries (1 / 100th of patients protected) for 36 months: 12 months before the deployment of telecommunication devices and 24 months after the deployment. The secondary population of the study will be constituted by the opinions requested by a general practitioner from an infectiological tele-advice system. The opinions requested during 12 months, from September 2018 to August 2019 will be recorded in the AIRBUS database.
You may qualify if:
- Every patients included in the general sample of beneficiaries database (secondary use of an existing cohort of anonymized patients)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
CH Notre Dame de la Miséricorde
Ajaccio, France
CH Annecy Genevois
Annecy, France
CH Métropole Savoie
Chambéry, France
Olivier.rogeaux@ch-metropole_savoie.fr
Chambéry, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Chu de Grenoble Alpes
Grenoble, France
Hospices civils de Lyon
Lyon, France
MIIT Lyon
Lyon, France
CH de Melun
Melun, France
CHU de Nice
Nice, France
Cochin, APHP
Paris, France
CHU Rennes
Rennes, France
CHU Saint Etienne
Saint-Etienne, France
Related Publications (9)
Gennai S, Francois P, Sellier E, Vittoz JP, Hincky-Vitrat V, Pavese P. Prospective study of telephone calls to a hotline for infectious disease consultation: analysis of 7,863 solicited consultations over a 1-year period. Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):509-14. doi: 10.1007/s10096-010-1111-z. Epub 2010 Nov 11.
PMID: 21069405BACKGROUNDSellier E, Labarere J, Gennai S, Bal G, Francois P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):887-94. doi: 10.1007/s10096-011-1172-7. Epub 2011 Feb 11.
PMID: 21311942BACKGROUNDBal G, Sellier E, Gennai S, Caillis M, Francois P, Pavese P. Infectious disease specialist telephone consultations requested by general practitioners. Scand J Infect Dis. 2011 Dec;43(11-12):912-7. doi: 10.3109/00365548.2011.598874. Epub 2011 Aug 26.
PMID: 21867475BACKGROUNDLesprit P, Landelle C, Brun-Buisson C. Unsolicited post-prescription antibiotic review in surgical and medical wards: factors associated with counselling and physicians' compliance. Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):227-35. doi: 10.1007/s10096-012-1734-3. Epub 2012 Aug 24.
PMID: 22918515BACKGROUNDMeeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016 Feb 9;315(6):562-70. doi: 10.1001/jama.2016.0275.
PMID: 26864410BACKGROUNDBernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017 Feb 1;46(1):348-355. doi: 10.1093/ije/dyw098.
PMID: 27283160BACKGROUNDPavese P, Sellier E, Laborde L, Gennai S, Stahl JP, Francois P. Requesting physicians' experiences regarding infectious disease consultations. BMC Infect Dis. 2011 Mar 14;11:62. doi: 10.1186/1471-2334-11-62.
PMID: 21401916BACKGROUNDBorowsky SJ. What do we really need to know about consultation and referral? J Gen Intern Med. 1998 Jul;13(7):497-8. doi: 10.1046/j.1525-1497.1998.00150.x. No abstract available.
PMID: 9686720BACKGROUNDKeating NL, Zaslavsky AM, Ayanian JZ. Physicians' experiences and beliefs regarding informal consultation. JAMA. 1998 Sep 9;280(10):900-4. doi: 10.1001/jama.280.10.900.
PMID: 9739974BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia PAVESE, MD
CHU de Grenoble Alpes
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2020
First Posted
October 26, 2020
Study Start
April 15, 2019
Primary Completion
June 30, 2022
Study Completion
December 31, 2022
Last Updated
May 30, 2023
Record last verified: 2023-05